Xeljanz XR 11 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F18XP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,312
Award facts
- Contract value 100% obligated
- $33,312.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $33.3K delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30-count units. This is a firm fixed-price, non-set-aside contract with performance scheduled for completion by December 4, 2025, and will be fulfilled at the vendor's Conshohocken, Pennsylvania location. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 million prime vendor agreement running through December 2026 that serves as the primary vehicle for pharmaceutical and medical supply distribution to military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal contracts with the Defense Logistics Agency covering a broad spectrum of medications and medical commodities. The company has demonstrated consistent capability to compete successfully for federal medical procurement requirements, with its DLA Troop Support Medical contract enabling it to supply critical pharmaceutical products including specialty medications, vaccines, and medical devices to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order for XELJANZ XR, a rheumatoid arthritis treatment, exemplifies the routine pharmaceutical resupply operations conducted under AmerisourceBergen's expansive prime vendor agreement.
Quick answers
Who was awarded contract SPE2DR26F18XP?
SPE2DR26F18XP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26F18XP worth?
The government has obligated $33,312 on SPE2DR26F18XP.
Is contract SPE2DR26F18XP an order under another contract?
Yes. SPE2DR26F18XP is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F18XP competed?
The extent of competition for SPE2DR26F18XP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award